SEQURNA® Thermostable RNase Inhibitor
Research tool for RNA protection in molecular biology
CommercialActive
Key Facts
Indication
Research tool for RNA protection in molecular biology
Phase
Commercial
Status
Active
Company
About Sequrna
Sequrna is a Stockholm-based biotech firm that has developed a next-generation, thermostable RNase inhibitor, a critical reagent for RNA sequencing. Unlike traditional protein-based inhibitors, Sequrna's synthetic product is stable at room temperature, simplifying logistics, reducing costs, and enabling novel experimental protocols involving heat cycles. The company's technology addresses key pain points in genomics workflows, including batch effects and sensitivity, positioning it as an innovator in the research tools market for advanced genomics applications.
View full company profile